Vanguard Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Vanguard Asset Management's ANIP Position: Q3 2026 in Review
Vanguard Asset Management reduced its ANI Pharmaceuticals (ANIP) stake by 15% in Q3 2026, selling an estimated $163K and leaving 12,346 shares worth $897K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.
Vanguard Asset Management first reported a position in ANIP in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.2M in Q2 2026. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Vanguard Asset Management held 12,346 shares of ANI Pharmaceuticals worth $897K as of Q3 2026.
- Vanguard Asset Management sold 2,115 ANI Pharmaceuticals shares in Q3 2026, an estimated $163K.
- ANI Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1908 holding.
- Vanguard Asset Management first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's ANI Pharmaceuticals position peaked at $1.2M in Q2 2026.
- 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.